News Release

Information
FY2022 Q3 Analyst Call Q&A Summary
Information
FY2022 Q2 Analyst Call Q&A Summary
Information
Chief Scientific Officer of Cullgen Inc. will be speaking at the 30th Annual Meeting of the Japanese Breast Cancer Society
Information
Beijing Continent enrolls the first subject of pirfenidone capsules Phase III clinical trial for pneumoconiosis
Information
FY2022 Q1 Analyst Call Q&A Summary
Information
GNI Group FY2021 Annual General Meeting Q&A Summary
Information
Frequently Asked Questions Updated File (2022-JAN-31)
Information
Frequently Asked Questions Updated (2022-JAN-31)
Information
2022 New Year Greeting
Information
GNI Group’s New Qualification as a Margin Trading Stock
Information
GNI Group Ltd. Ranks 32nd in 2021 Japan Technology Fast 50
Information
Berkeley Advanced Biomaterials LLC Exhibited in the U.S. and China Orthopedics Conferences
Information
Cullgen Announces Prominent Publication by Cullgen Co-Founders Jian Jin and Yue Xiong in Nature Reviews Cancer
Information
Ranked in the Financial Times, “High-Growth Companies Asia-Pacific 2021” for the second consecutive year
Information
New Year Greeting